Faculty, UW School of Medicine and Public Health

Laura J. Buyan Dent, MD, PhD

  • Neurology

About

Dr. Buyan Dent is a neurologist in the Movement Disorders Program. Dr. Buyan Dent's main focus is the care of patients with Parkinson's disease, Huntington's disease, essential tremor, dystonia, multiple systems atrophy, progressive supranuclear palsy and other movement disorders. With state-of-the-art pharmaceutical treatments, botulinum toxin injections and surgical management options, Dr. Buyan Dent helps patients with a unique program that suits their particular conditions.

As part of the Performing Arts Medicine Program, she is dedicated to the care of artists with neurologic conditions such as tremors, dystonias and ataxias, that may interfere with performance and movement. She also helps with performance-related overuse conditions or injuries that result in focal dystonia, nerve injuries, weakness, tremors and coordination difficulties.

Languages spoken
  • English
University affiliation

Practice locations

    Education & credentials

    Board certifications
    • Neurology
    Medical School
    • University of Wisconsin School of Medicine and Public Health (formerly UW Medical School), Madison, WI
    Fellowships
    • Boston Medical Center, Boston, MA
    Residencies
    • University of Wisconsin Hospitals and Clinics, Madison, WI
    Internships
    • University of Wisconsin Hospitals and Clinics, Madison, WI

    Specialties

    Additional conditions and treatments
    • Botulinum Toxin Muscle Injection
    • Chorea
    • Deep Brain Stimulation Management
    • Dystonia
    • Gait Disorder
    • Huntington's Disease
    • Movement Disorders
    • Myoclonus
    • Performing Arts Medicine - Neurological Conditions and Movement Disorders
    • Restless Leg Syndrome
    • Tardive Dyskinesia
    • Torticollis
    • Tourette Syndrome
    • Tremors
    • Wilson's Disease

    Research and publications

    Dr. Buyan Dent's previous research examined the rehabilitation of patients with atypical parkinsonian disorders. She hopes to implement clinical research trials to expand treatment options and knowledge in both Parkinson's and Huntington's Disease.